Biochemistry

Pyridoxal Phosphate (PLP): The Vitamin B6 Cofactor of Transamination

A single vitamin B6 molecule, wearing an aldehyde "hook" and an electron-hungry pyridine ring, sits at the heart of more than 160 distinct enzyme activities — roughly 4% of all classified enzyme reactions. That molecule is pyridoxal 5'-phosphate (PLP), and its most famous job is transamination: swapping the amino group off one amino acid and parking it onto a keto acid, the reaction that lets your liver funnel dietary protein into the citric acid cycle.

PLP is the biologically active, phosphorylated form of vitamin B6. In transaminases (aminotransferases) it works as an "electron sink," stabilizing the negatively charged reaction intermediates that would otherwise be prohibitively unstable. The result is a reversible, two-half-reaction shuttle — best illustrated by aspartate aminotransferase — that interconverts amino acids and α-keto acids at the crossroads of nitrogen and carbon metabolism.

  • TypeEnzyme cofactor (prosthetic group), aldehyde form of vitamin B6
  • Molecular formulaC8H10NO6P, MW ~247 g/mol
  • Key reactionTransamination (amino group transfer) via ping-pong bi-bi
  • Anchoring residueActive-site lysine (e.g., Lys258 in E. coli AspAT)
  • Adult RDA (B6)1.3 mg/day; plasma PLP ~30-110 nmol/L
  • DiscoveredVitamin B6 isolated 1938; PLP role in transamination 1940s-50s

Interactive visualization

Press play, or step through manually. The visualization is yours to drive — try it before reading on.

Open visualization fullscreen ↗

Watch the 60-second explainer

A condensed visual walkthrough — narrated, captioned, under a minute.

What PLP Is and Where Transamination Happens

Pyridoxal 5'-phosphate is the aldehyde, phosphorylated form of vitamin B6 (pyridoxine). Its business end has three functional features: a reactive C4' aldehyde, a protonated pyridinium nitrogen (N1) that acts as an electron sink, and a 5'-phosphate that clamps the cofactor into the enzyme. Cells generate PLP from dietary B6 vitamers via pyridoxal kinase (PDXK) and pyridoxine-5'-phosphate oxidase (PNPO).

Transaminases (aminotransferases) are found in essentially every cell, but the reaction is concentrated in the liver, where amino acids are catabolized, and in skeletal muscle. Two clinically famous ones — aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) — funnel amino nitrogen toward glutamate, the gateway substrate for the urea cycle.

  • Cellular free PLP is kept very low (micromolar) because free PLP is chemically reactive and mildly toxic; most is bound to enzymes.
  • Each transaminase carries one PLP per subunit, tethered to a conserved active-site lysine.

The Mechanism, Step by Step

Transamination proceeds by a ping-pong bi-bi (double-displacement) mechanism with two half-reactions:

  • Internal aldimine: At rest, PLP's aldehyde is joined to the active-site lysine (e.g., Lys258 in E. coli AspAT) as a Schiff base — the internal aldimine.
  • Transaldimination: The incoming amino acid's α-amino group displaces the lysine, forming the external aldimine (PLP-substrate Schiff base).
  • Cα deprotonation: The freed lysine acts as a base and abstracts the α-hydrogen. The resulting carbanion is stabilized by delocalization into the ring — the resonance-stabilized quinonoid intermediate. This is PLP's core trick: the electron sink.
  • Ketimine and hydrolysis: Reprotonation at C4' gives a ketimine, which hydrolyzes to release the α-keto acid and leave the cofactor as pyridoxamine 5'-phosphate (PMP).

The second half-reaction runs in reverse: PMP condenses with a new α-keto acid (typically α-ketoglutarate), transfers the amino group, and regenerates PLP plus a new amino acid (glutamate).

Key Molecules and a Worked Example

The textbook example is aspartate aminotransferase (AspAT/AST), a ~45 kDa-per-subunit homodimer:

L-aspartate + α-ketoglutarate ⇌ oxaloacetate + L-glutamate

  • Substrates in: L-aspartate donates its amino group; α-ketoglutarate accepts it.
  • Products out: oxaloacetate (a citric-acid-cycle intermediate) and L-glutamate.
  • The reaction is near-equilibrium (ΔG ≈ 0), so it runs in either direction depending on substrate concentrations — no net energy is consumed.

Dunathan's stereoelectronic hypothesis (1966) explains reaction specificity: the bond to be broken at Cα is held perpendicular to the PLP ring plane so its breaking electrons align with the π-system. Rotating a different bond into that position is how the same cofactor supports transamination in one enzyme and decarboxylation in another.

  • Diagnostic numbers: serum AST reference ~10-40 U/L; ALT ~7-56 U/L; both spike in hepatocyte injury.

How It Is Studied, Observed, and Regulated

PLP chemistry is unusually easy to watch because the intermediates are colored. The internal aldimine absorbs near 430 nm, while the quinonoid intermediate produces a striking peak around 490-510 nm — so stopped-flow UV/Vis spectroscopy can time individual steps on the millisecond scale.

  • Structural biology: AspAT was among the first PLP enzymes crystallized; X-ray structures caught it in the open/closed conformations, revealing an induced-fit domain closure over the substrate.
  • Isotope labeling: ³H at Cα and NMR track proton transfer and confirm the 1,3-prototropic shift between C4' and Cα.
  • Inhibitors: aminooxyacetate and gabaculine trap PLP; vigabatrin is a suicide inhibitor of GABA transaminase used as an anticonvulsant.

Regulation: transaminase levels respond to protein intake and glucocorticoids; PLP availability itself is controlled by PNPO and by phosphatases that dephosphorylate PLP to allow membrane transport, keeping free intracellular PLP low.

Every PLP reaction starts identically — internal aldimine → external aldimine → labilized Cα — but then diverges by which bond breaks:

  • Transamination breaks the Cα-H bond and, uniquely, leaves the amino group on the cofactor (as PMP) before handing it to a second substrate. This is why it needs two half-reactions.
  • Decarboxylation (e.g., glutamate → GABA by GAD, or DOPA → dopamine) breaks the Cα-COO⁻ bond, releasing CO2 — a one-way reaction that manufactures neurotransmitters.
  • Racemization (alanine racemase) removes and re-adds the α-proton from the opposite face, generating D-amino acids for bacterial cell walls — a key antibiotic target.
  • β/γ reactions (serine hydroxymethyltransferase, cystathionine β-synthase) act on side-chain carbons, feeding one-carbon and sulfur metabolism.

Contrast this with other cofactors: thiamine pyrophosphate also handles α-carbon chemistry but stabilizes an acyl carbanion, while biotin and NAD⁺ do carboxylation and redox — none provide PLP's amino-shuttle electron sink.

Significance, Disease, and Open Questions

Because PLP sits astride amino-acid metabolism, its failures ripple widely:

  • Diagnostics: AST and ALT are the most-ordered liver-function markers on Earth; the AST/ALT (De Ritis) ratio helps distinguish alcoholic (>2) from viral hepatitis.
  • Neurology: because glutamate decarboxylase (GABA synthesis) and aromatic amino acid decarboxylase (dopamine/serotonin) are PLP enzymes, severe B6 deficiency causes seizures. PNPO deficiency and ALDH7A1 mutations cause pyridoxine-dependent epilepsy, treated with high-dose B6.
  • Vascular risk: PLP-dependent cystathionine β-synthase deficiency causes homocystinuria and elevated homocysteine.
  • Pharmacology: the TB drug isoniazid depletes PLP (hence co-prescribed B6); penicillamine and hydrazines do the same.

Open questions include how apo-enzymes acquire PLP without free-PLP toxicity (chaperone-like delivery is debated), how PNPO hands PLP directly to client enzymes, and how to engineer transaminases as green catalysts for chiral-amine drug synthesis — an active industrial biocatalysis frontier.

Four major reaction classes catalyzed by PLP-dependent enzymes, all beginning from the same external aldimine but cleaving a different bond at the α-carbon.
Reaction classBond broken at CαRepresentative enzymeProduct / role
TransaminationC-H (α-hydrogen)Aspartate aminotransferase (AST/GOT)α-keto acid + pyridoxamine phosphate
DecarboxylationC-COO⁻Glutamate decarboxylase (GAD)Amine (e.g., GABA) + CO2
RacemizationC-H (reprotonation)Alanine racemaseD-amino acid (bacterial cell wall)
β/γ-elimination or replacementCβ/Cγ side chainSerine hydroxymethyltransferase; cystathionine β-synthaseOne-carbon units; H2S / cysteine synthesis

Frequently asked questions

Why does transamination need pyridoxal phosphate specifically?

The reaction generates a carbanion at the α-carbon of the amino acid, which is far too unstable to form on its own. PLP's protonated pyridine nitrogen acts as an 'electron sink,' delocalizing that negative charge into the ring as a resonance-stabilized quinonoid intermediate. No ordinary amino acid side chain can stabilize this charge, so PLP is essentially irreplaceable for the chemistry.

What is the difference between PLP and PMP?

Pyridoxal 5'-phosphate (PLP) carries an aldehyde at C4' and is the resting form of the cofactor. During the first half of transamination it accepts the amino group and becomes pyridoxamine 5'-phosphate (PMP), which bears an amino-methyl group at C4'. The second half-reaction hands that amino group to an α-keto acid and regenerates PLP. So the cofactor cycles PLP ⇌ PMP each catalytic turnover.

What is the internal aldimine and why does it matter?

Before any substrate binds, PLP's aldehyde forms a Schiff base with the ε-amino group of a conserved active-site lysine (Lys258 in E. coli aspartate aminotransferase). This is the internal aldimine. It pre-organizes and activates the cofactor; when substrate arrives, a transaldimination swaps the lysine out for the amino acid, and the freed lysine then serves as the catalytic base that removes the α-proton.

Why is transamination called a 'ping-pong' mechanism?

Because the two substrates never sit on the enzyme at the same time. The amino donor binds, gives up its amino group (leaving PMP), and the α-keto product leaves — that is the 'ping.' Only then does the second substrate, an α-keto acid, bind and pick up the amino group — the 'pong.' This double-displacement, with a modified cofactor as the intermediate, is the signature of ping-pong bi-bi kinetics.

How does the same cofactor do transamination, decarboxylation, and racemization?

Dunathan's stereoelectronic hypothesis (1966) is the answer: the enzyme orients the amino acid so that the specific bond to be broken lies perpendicular to the plane of the PLP ring, aligning its electrons with the ring's π-system. A transaminase points the Cα-H bond that way; a decarboxylase points the Cα-COO⁻ bond. The cofactor is identical — the protein scaffold selects the chemistry.

Why are AST and ALT measured in blood tests?

Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are abundant transaminases inside hepatocytes and, for AST, cardiac and skeletal muscle. When those cells are damaged, the enzymes leak into serum, so elevated levels flag liver injury. Normal ranges are roughly AST 10-40 U/L and ALT 7-56 U/L; the AST/ALT ratio helps distinguish the cause of hepatocellular damage.

What happens in vitamin B6 deficiency?

Because dozens of enzymes depend on PLP, deficiency broadly disrupts amino-acid and neurotransmitter metabolism. Reduced GABA synthesis (via glutamate decarboxylase) lowers the seizure threshold, and impaired cystathionine β-synthase raises homocysteine. Deficiency can be dietary or drug-induced — isoniazid, for instance, binds and depletes PLP, which is why patients receive supplemental B6. Inherited PNPO or ALDH7A1 defects cause B6-responsive neonatal epilepsy.